Cytori
Therapeutics, Inc. (NASDAQ:CYTX) will webcast their corporate
presentation at the Biotech Showcase™ at 11:00 AM PT (2:00 PM ET)
on Monday, January 13. The presentation will be held in the Mission II
room of the Parc 55 Wyndham Hotel in San Francisco.
The presentation webcast
may be accessed on the "Webcasts" page of the Investor Relations section
of the Company's website. The webcast can be accessed live and will be
available for replay approximately one hour after the presentation on
the Company's website.
In addition, Cytori’s CEO Chris Calhoun will be participating in a panel
at the Alliance for Regenerative Medicine’s (ARM) State of the Industry
Briefing. The panel discussion will be filmed and will be made available
at a later date on the ARM website. The details are as follows:
Biotech
Showcase™ 2014: ARM’s Regenerative Medicine State of the Industry
Briefing
|
Panel:
|
|
|
|
|
|
|
|
|
Recent Financings in the Sector
|
|
Date:
|
|
|
|
|
|
|
|
|
January 13, 2014
|
|
Time:
|
|
|
|
|
|
|
|
|
9:00 – 9:45 AM PT
|
|
Location:
|
|
|
|
|
|
|
|
|
Parc 55 Wyndham, 55 Cyril Magnin Street, San Francisco, CA
|
|
|
|
|
|
|
|
|
|
|
Cyril Magnin Ballroom - 4th Floor
|
|
|
|
|
|
|
|
|
|
|
|
About Cytori
Cytori Therapeutics is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular
disease and other medical conditions. Our scientific data suggest ADRCs
improve blood flow, moderate the inflammatory response and keep tissue
at risk of dying alive. As a result, we believe these cells can be
applied across multiple “ischemic” conditions. These therapies are made
available to the physician and patient at the point-of-care by Cytori’s
proprietary technologies and products, including the Celution System
product family. www.cytori.com
Copyright Business Wire 2014